Home › Compare › DRSLF vs JNJ

DRSLF vs JNJ: Dividend Comparison 2026

DRSLF yields 57.39% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DRSLF wins by $552.8K in total portfolio value
10 years
DRSLF
DRSLF
● Live price
57.39%
Share price
$3.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$572.8K
Annual income
$129,377.33
Full DRSLF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DRSLF vs JNJ

📍 DRSLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDRSLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DRSLF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DRSLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DRSLF
Annual income on $10K today (after 15% tax)
$4,878.27/yr
After 10yr DRIP, annual income (after tax)
$109,970.73/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DRSLF beats the other by $109,267.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DRSLF + JNJ for your $10,000?

DRSLF: 50%JNJ: 50%
100% JNJ50/50100% DRSLF
Portfolio after 10yr
$296.4K
Annual income
$65,102.56/yr
Blended yield
21.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DRSLF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DRSLF buys
0
JNJ buys
0
No recent congressional trades found for DRSLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDRSLFJNJ
Forward yield57.39% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$572.8K ✓$20.0K
Annual income after 10y$129,377.33 ✓$827.78
Total dividends collected$470.9K ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DRSLF vs JNJ ($10,000, DRIP)

YearDRSLF PortfolioDRSLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$16,439$5,739.14$10,676$355.77+$5.8K → DRSLF
2$26,407$8,817.44$11,407$389.39+$15.0K → DRSLF
3$41,493$13,237.44$12,198$426.53+$29.3K → DRSLF
4$63,837$19,438.98$13,056$467.62+$50.8K → DRSLF
5$96,255$27,950.08$13,987$513.12+$82.3K → DRSLF
6$142,380$39,387.06$14,998$563.56+$127.4K → DRSLF
7$206,797$54,449.60$16,098$619.52+$190.7K → DRSLF
8$295,183$73,910.16$17,295$681.69+$277.9K → DRSLF
9$414,443$98,597.89$18,599$750.82+$395.8K → DRSLF
10$572,832$129,377.33$20,022$827.78+$552.8K → DRSLF

DRSLF vs JNJ: Complete Analysis 2026

DRSLF — Stock

Dorsel Holdings Ltd engages in the construction, development, and rental of real estate properties in Israel. The company was founded in 1995 and is based in Yokneam, Israel. Dorsel Holdings Ltd is a subsidiary of Synel M.L.L Payway Ltd.

Full DRSLF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DRSLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DRSLF vs SCHDDRSLF vs JEPIDRSLF vs ODRSLF vs KODRSLF vs MAINDRSLF vs ABBVDRSLF vs MRKDRSLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.